
Cancer Treatment
UCLA develops new immune cell therapy to battle deadly kidney cancer
UCLA’s new off-the-shelf cell therapy shows promise against hard-to-treat kidney cancer, bypassing the need for patient-specific treatments.
Joseph Shavit
